These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 16871467

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
    Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G, Arbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie.
    Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of psychotropic drugs: pharmacological and clinical relevance.
    Daniel W.
    Pol J Pharmacol; 1995 Nov; 47(5):367-79. PubMed ID: 8868127
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
    Baumann P, Hiemke C, Ulrich S, Eckermann G, Kuss HL, Laux G, Müller-Oerlingenhausen B, Rao ML, Riederer P, Zernig G, AGNP-TDM, Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) - Therapeutic Drug Monitoring (TDM).
    Rev Med Suisse; 2006 May 24; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence.
    Ulrich S, Hiemke C, Laux G, Müller-Oerlinghausen B, Havemann-Reinecke U, Riederer P, Zernig G, Baumann P, TDM group of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP).
    Pharmacopsychiatry; 2007 May 24; 40(3):121-7. PubMed ID: 17541888
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of psychotropic drugs in special populations.
    Rudorfer MV.
    J Clin Psychiatry; 1993 Sep 24; 54 Suppl():50-4; discussion 55-6. PubMed ID: 8407858
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations].
    Gerlach M, Rothenhöfer S, Mehler-Wex C, Fegert JM, Schulz E, Wewetzer C, Warnke A.
    Z Kinder Jugendpsychiatr Psychother; 2006 Jan 24; 34(1):5-13. PubMed ID: 16485609
    [Abstract] [Full Text] [Related]

  • 13. Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results.
    Jones AW, Holmgren A, Kugelberg FC.
    Ther Drug Monit; 2007 Apr 24; 29(2):248-60. PubMed ID: 17417081
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.
    DeVane CL, Stowe ZN, Donovan JL, Newport DJ, Pennell PB, Ritchie JC, Owens MJ, Wang JS.
    J Psychopharmacol; 2006 Jul 24; 20(4 Suppl):54-9. PubMed ID: 16785271
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Therapeutic drug monitoring: clinical practice].
    Widmer N, Werner D, Grouzmann E, Eap CB, Marchetti O, Fayet A, Csajka C, Decosterd LA, Buclin T.
    Rev Med Suisse; 2008 Jul 16; 4(165):1649-50, 1652-60. PubMed ID: 18767291
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.